Multidrug Resistance-Associated Proteins
"Multidrug Resistance-Associated Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sequence-related subfamily of ATP-BINDING CASSETTE TRANSPORTERS that actively transport organic substrates. Although considered organic anion transporters, a subset of proteins in this family have also been shown to convey drug resistance to neutral organic drugs. Their cellular function may have clinical significance for CHEMOTHERAPY in that they transport a variety of ANTINEOPLASTIC AGENTS. Overexpression of proteins in this class by NEOPLASMS is considered a possible mechanism in the development of multidrug resistance (DRUG RESISTANCE, MULTIPLE). Although similar in function to P-GLYCOPROTEINS, the proteins in this class share little sequence homology to the ATP-BINDING CASSETTE, SUB-FAMILY B, MEMBER 1 family of proteins.
Descriptor ID |
D027425
|
MeSH Number(s) |
D12.776.157.530.100.304 D12.776.157.530.450.074.500.500.500 D12.776.543.585.100.304 D12.776.543.585.450.074.500.500.500
|
Concept/Terms |
Multidrug Resistance-Associated Proteins- Multidrug Resistance-Associated Proteins
- Multidrug Resistance Associated Proteins
- Multispecific Organic Anion Transporter
- Multispecific Organic Anion Transport Proteins
- ATP-Binding Cassette, Sub-Family C Proteins
- ATP Binding Cassette, Sub Family C Proteins
- MOAT Protein
- Multidrug Resistance-Associated Protein
- Multidrug Resistance Associated Protein
- Resistance-Associated Protein, Multidrug
|
Below are MeSH descriptors whose meaning is more general than "Multidrug Resistance-Associated Proteins".
Below are MeSH descriptors whose meaning is more specific than "Multidrug Resistance-Associated Proteins".
This graph shows the total number of publications written about "Multidrug Resistance-Associated Proteins" by people in this website by year, and whether "Multidrug Resistance-Associated Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 3 | 3 |
1997 | 1 | 4 | 5 |
1998 | 0 | 3 | 3 |
1999 | 1 | 0 | 1 |
2000 | 4 | 4 | 8 |
2001 | 0 | 2 | 2 |
2002 | 5 | 0 | 5 |
2003 | 1 | 1 | 2 |
2004 | 1 | 1 | 2 |
2005 | 0 | 2 | 2 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 1 | 2 | 3 |
2009 | 2 | 4 | 6 |
2010 | 2 | 2 | 4 |
2011 | 1 | 1 | 2 |
2012 | 2 | 0 | 2 |
2015 | 2 | 1 | 3 |
2016 | 1 | 1 | 2 |
2017 | 0 | 2 | 2 |
2018 | 1 | 0 | 1 |
2019 | 1 | 1 | 2 |
2020 | 0 | 1 | 1 |
2021 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multidrug Resistance-Associated Proteins" by people in Profiles.
-
In situ structure of the AcrAB-TolC efflux pump at subnanometer resolution. Structure. 2022 01 06; 30(1):107-113.e3.
-
Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells. Sci Rep. 2021 04 28; 11(1):9149.
-
Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene. Pediatr Blood Cancer. 2021 08; 68(8):e29036.
-
[131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma. Nucl Med Biol. 2020 Nov - Dec; 90-91:49-54.
-
In situ structure and assembly of the multidrug efflux pump AcrAB-TolC. Nat Commun. 2019 06 14; 10(1):2635.
-
A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity. Cell Rep. 2019 02 05; 26(6):1544-1556.e8.
-
Classic pseudoxanthoma elasticum in a girl with sickle cell disease. Pediatr Dermatol. 2019 Jan; 36(1):e64-e65.
-
Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions. Exp Hematol. 2017 08; 52:65-71.
-
Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro. Toxicol In Vitro. 2017 Jun; 41:75-82.
-
Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy. Oncotarget. 2016 Sep 27; 7(39):63829-63838.